Fariba Khanshan, PhD (she/her/hers)

PK/PD/PMX
AstraZeneca/Novartis
BROOKLINE, Massachusetts, United States

Fariba Khanshan, PhD, is Director of PK/PD/PMX at AstraZeneca. She leads clinical pharmacology strategies, exposure–response and population PK/PD analyses to optimize dose selection and accelerate oncology drug development. Since 2020, she has advanced radioconjugate programs through end-of-phase analyses, dose optimization, and translational modeling. She earned her PhD in Chemical Engineering.

Disclosure information not submitted.

Presentation(s):

• Advances in Mathematical and Computational Modeling for Radiopharmaceutical Therapies

  Tuesday, October 21, 2025
  9:00 AM - 10:30 AM MDT

• Reduced dosimetry using NLME

  Tuesday, October 21, 2025
  10:07 AM - 10:30 AM MDT